CONFERENCES

      Microphysiological System World Summit

      MPS World Summit is an annual conference that focuses on the  advances in microphysiological system technology, with a wide range of topics ranging from toxicology to regulatory sciences. The event is aimed at scientists, engineers, and industry leaders, and provides a forum for sharing knowledge and collaborating on the latest advances in the field. 

      MPS World Summit 2024

      Date

      Jun 10, 2024 - Jun 14, 2024

      Location

      Seattle, USA

      The MPS World Summit 2024 promises to be a pivotal event for advancing MPS research and fostering collaboration within this innovative scientific community.

      The summit features several pre-conference events, including the Workshop for Advancing Standards and Regulatory Science for MPS and Microfluidic-based Medical Products, gathering regulators and stakeholders to discuss MPS standards development. Another event, "Walk and Talk at the U," takes place at the University of Washington, offering interactive educational networking. Additionally, the 24th NIH Tissue Chip Consortium Meeting is held for NIH-funded investigators.

      MPS Summit 2023

      Date

      Jun 26, 2023 - Jun 30, 2023

      Location

      Berlin, Germany

      Organized together with International MPS Society (iMPSS) and European Organ-on-Chip Society (EUROoCS), the Microphysiological System Summit 2023 includes satellite events, networking opportunities, and educational workshop. The scientific sessions include varying formats: workshops, roundtables, and scientific symposia.

      MPS Summit 2022

      Date

      May 30, 2022 - Jun 03, 2022

      Location

      New Orleans, USA

      Bringing over 650 delegates with 70% attending in person, this summit is organized by the Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and EUROoCS, with the support of more than forty organizations.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.